Filing Flows › Boston Scientific (BSX) › R&D spending
Boston Scientific (BSX) R&D spending by quarter
Boston Scientific's R&D spending was $520M in Q3 2026 (third quarter 2026), -6% from Q2 2026. Over the last 7 quarters it ranged from $443M (Q1 2025) to $569M (Q4 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $520M | -6% | +1% |
| Q2 2026 | $554M | +7% | +5% |
| Q1 2026 | $516M | -9% | +16% |
| Q4 2025 | $569M | +11% | — |
| Q3 2025 | $514M | -2% | — |
| Q2 2025 | $526M | +19% | — |
| Q1 2025 | $443M | — | — |
Q3 2026 at a glance
Boston Scientific, Q3 2026: revenue $5.1B (+1% year over year), operating margin 16.1%, net earnings $580M, operating cash flow $1.0B. The chart follows the revenue to costs, profit and cash.
Questions
What is Boston Scientific's R&D spending?
Boston Scientific's R&D spending was $520M in Q3 2026 (third quarter 2026), -6% from Q2 2026.
How has Boston Scientific's R&D spending changed?
Over the last 7 quarters it ranged from $443M (Q1 2025) to $569M (Q4 2025).